Coetzee, T;
Thompson, AJ;
(2018)
Unified understanding of MS course is required for drug development.
Nature Reviews Neurology
, 14
pp. 191-192.
10.1038/nrneurol.2017.184.
Preview |
Text
Thompson_NNeurolRevs-Unified understanding11.12.17.pdf - Accepted Version Download (253kB) | Preview |
Abstract
The treatment of multiple sclerosis (MS) has evolved remarkably over the past 25 years. This progress has been enabled by advances in research, drug development and active engagement of the scientific community with regulatory authorities. However, an inconsistent approach to MS disease courses could have a negative impact on the drug development process.
| Type: | Article |
|---|---|
| Title: | Unified understanding of MS course is required for drug development |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/nrneurol.2017.184 |
| Publisher version: | http://doi.org/10.1038/nrneurol.2017.184 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10042278 |
Archive Staff Only
 |
View Item |
